Signature Bank (SBNY - Get Report) was upgraded to overweight, Barclays said. $139 price target. Commercial real estate risk is exaggerated and the company can deliver above-average growth, according to Barclay's.
Select Medical (SEM - Get Report) was downgraded to underperform from market perform, JMP Securities said. $10 price target. Estimates were cut, too, given lower expected earnings in the long-term care hospital business, according to JMP.
Workday (WDAY - Get Report) was upgraded to neutral from underperform, Wedbush said. $82 price target. Investor sentiment is improving and sales should recover in the second half of the year, said Wedbush.